News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Giannis Mountzios/LinkedIn
May 11, 2025, 13:57

Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC

Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X about a paper by Marcel Wiesweg et al. published in the Journal of Thoracic Oncology:

“Excellent report in Journal of Thoracic Oncology⁦⁩ shedding light on factors influencing treatment sequence in BRAF mutant NSCLC.

  • Identical OS 28 m with TKI combo vs chemo/IO
  • Gender impact! F > M with BRAF/MEK but F=M with IO (confounder: smoking?).”

Title: Treatment sequences in BRAF-V600-mutated non-small cell lung cancer: First-line targeted therapy versus first-line (chemo-) immunotherapy

Authors: Marcel Wiesweg, Ali Alaffas, Anna Rasokat, Felix Carl Saalfeld, Maximilian Rost, Christin Assmann, Franziska Herster, Moritz Hilbrandt, Frank Griesinger, Anna Kron, Julia Roeper, Franziska Glanemann, Cornelia Kropf-Sanchen, Martin Reck, Jonas Kulhavy, Albrecht Stenzinger, Jürgen Wolf, Martin Sebastian, Martin Schuler, Martin Wermke, Nikolaj Frost, Hans-Georg Kopp, Petros Christopoulos, Matthias Scheffler.

Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC

Read the Full Article in Journal of Thoracic Oncology.

More posts featuring Giannis Mountzios.

Albrecht Stenzinger Ali Alaffas Anna Kron Anna Rasokat cancer Christin Assmann Cornelia Kropf-Sanchen Felix Carl Saalfeld Frank Griesinger Franziska Glanemann Franziska Herster Giannis Mountzios Hans-Georg Kopp immunotherapy Jonas Kulhavy Journal of Thoracic Oncology Julia Roeper Jürgen Wolf Marcel Wiesweg Martin Reck Martin Schuler Martin Sebastian Martin Wermke Matthias Scheffler Maximilian Rost Moritz Hilbrandt Nikolaj Frost non small cell lung cancer NSCLC OncoDaily Oncology Petros Christopoulos
Special Coverage
Science
May 11, 2025, 13:57
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Blog
May 11, 2025, 13:56
Alfonso Duenas Gonzalez: Quite odd, do not you believe?
Oncolibrary
May 11, 2025, 13:51
FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results
Blog
May 11, 2025, 13:41
In Palliative Care and Beyond, a Mother’s Love is a Healing Force - ACREOL Global
Blog
May 11, 2025, 13:29
Freddy E Escorcia: Departure from NCI After Nearly Nine Years
Blog
May 11, 2025, 13:13
Shahrin Ahmed: Are Breast Cancer Outcomes in Women Improved by RiskScore Testing?
Blog
May 11, 2025, 12:41
Aria Vaishnavi: First Preprint From My Lab on ERBB Signaling in BRAFV600E-Driven Lung Cancer
Insight
May 11, 2025, 12:06
Bobby Koneru: First Modern American Case Series on Treating Osteoarthritis with Low-Dose Radiotherapy
Blog
May 11, 2025, 11:55
Filippo Alongi: Radiotherapy Innovation Recognized at ESTRO 2025
Blog
May 11, 2025, 11:48
Stephen V Liu: Yilong Wu shows the Potential of PD1/VEGF Bispecifics in driver positive NSCLC at RomeLung25
Insight
May 11, 2025, 11:37
Aman Chauhan: Latest ASCO guidelines on functional Neuroendocrine Tumors (NETs)
Blog
May 11, 2025, 11:35
Helena Linardou: Visionary lecture from Faisal Mahmood here at AI for Oncology